PharmaRadar360

PharmaRadar360

🌍·19h agoResearch

Figure 2 from: Nikolov D, Nikolov G, Kitova L, Kitov S, Kitova M-F, Mihaylova AA (2026) Rituximab therapy in severe PR3-ANCA pulmonary–renal syndrome: A clinical and pharmaceutical case report. Pharmacia 73: e201634. https://doi.org/10.3897/pharmacia.73.e201634

Publisher

C
Crossref

Global

This page provides publisher metadata, and related coverage to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
Crossref
Region
Global
Scope
Research
Published
September 16, 2026
Language
EN

Publisher context, original article off-platform

This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.

Source route

Continue on doi.org

Leave the platform to read the original full article on the publisher site.

Source: Crossref

Scope: Research

Open original article
Figure 2 from: Nikolov D, Nikolov G, Kitova L, Kitov S, Kitova M-F, Mihaylova AA (2026) Rituximab therapy in severe PR3-ANCA pulmonary–renal syndrome: A clinical and pharmaceutical case report. Pharmacia 73: e201634. https://doi.org/10.3897/pharmacia.73.e201634 | PharmaRadar360